Press Release

Los Alamos, N.M., February 11, 2009 –- Manhattan Scientifics, Inc. (Pink Sheets: MHTX) announced today that it successfully completed a $1.0 million private placement of equity for general-purpose working capital.

Manhattan Scientifics is planning to achieve full compliance with SEC filings and to regain its full reporting status. On February 3rd, the company filed fiscal year 2007 Form 10-K. The company is diligently working with its auditors to file the remaining Form 10-Qs for 2008 quarterly reports. Upon completion of these filings, the company will immediately apply to be relisted on the OTC Bulletin Board.

CEO Manny Tsoupanarias said, "Now that our nano-titanium dental implant metal has been approved for medical use by the U.S. Food and Drug Administration (FDA), we have opened serious discussions with medical device and prosthetics manufacturers regarding the use of our fine-grain metals."

Chairman Emeritus Marvin Maslow added, "Discussions are underway with a quality, deep-pocket, North America-based NYSE metal alloys manufacturer to mass produce nanostructured metal alloys under license from us. There is great interest expressed by both parties in these discussions."

Manhattan Scientifics, Inc., http://www.mhtx.com/, is located in New Mexico, New York, and Montreal. It is developing and plans to acquire technologies in a variety of
environmentally friendly energy and other people-friendly industries. Copies of Manhattan Scientifics' press releases and related investor information may also be
found at http://www.hawkassociates.com/.

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause
the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and
are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

Executive Contacts:
Los Alamos National Labs - Kevin Roark
Email: kroak@anl.go
Phone: 505-665-9202

Metallicum, Inc. - Dr. Terry Lowe
Email: tlowe@metallicum.com
Phone: 505-670-8755

For Investor Relations contact MHTX Chairman Emeritus Marvin Maslow
Email: marvin@marvinmaslow.com
Phone: 917-923-3300

Manhattan Scientifics Completes $1.0 Million Equity Raise

February 2nd, 2009